LGLQX | VIGAX | LGLQX / VIGAX | |
Total Expense Ratio | 1.25 | 0.05 | 2,500% |
Annual Report Gross Expense Ratio | 1.25 | 0.05 | 2,500% |
Fund Existence | 14 years | 25 years | - |
Gain YTD | 14.956 | 11.893 | 126% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.87B | 324B | 2% |
Annual Yield % from dividends | 0.00 | 0.43 | - |
Returns for 1 year | 43.06 | 29.38 | 147% |
Returns for 3 years | 73.03 | 73.56 | 99% |
Returns for 5 years | 35.38 | 106.37 | 33% |
Returns for 10 years | 116.95 | 321.09 | 36% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NUAG | 21.01 | 0.02 | +0.10% |
Nuveen Enhanced Yield US Aggt Bd ETF | |||
BMED | 24.78 | -0.03 | -0.14% |
iShares Health Innovation Active ETF | |||
FVAL | 65.38 | -0.11 | -0.17% |
Fidelity Value Factor ETF | |||
ELCV | 25.77 | -0.12 | -0.46% |
Eventide High Dividend ETF | |||
MLPB | 25.46 | -0.25 | -0.99% |
UBS ETRACS Alerian MLPInfrs ETN SerB |